Início › DPOC › Carolina do Norte
Ensaios clínicos de DPOC em Carolina do Norte
22 estudos para DPOC estão buscando participantes em locais em Carolina do Norte.
Cidades em Carolina do Norte
Texto oficial do estudo (Inglês)
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
RecrutandoFase 2
Idades de 40 a 85 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07684820A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
RecrutandoFase 4
Idades de 40 a 85 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- e mais 1
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07190209A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
RecrutandoFase 2
Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07190222Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
RecrutandoFase 4
Idades 60 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- e mais 1
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06878261A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
RecrutandoEstudo observacional
Idades 40 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
RecrutandoFase 2/3
Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Recrutando
Todas as idades · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT07031336A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- e mais 3
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06283966STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
RecrutandoFase 3
Idades de 40 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 30 a 55 · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Recrutando
Idades de 40 a 80 · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT07051707Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06961214Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de fev. de 2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
RecrutandoEstudo observacional
Idades 50 e acima · Todos os sexos · Atualizado em 5 de ago. de 2025 · NCT06122077Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.